On March 1, 2010
Big Pharma’s Secret Tax Problem: As Drugs Patents Expire, the IRS Wants Its Pound of Flesh
Big Pharma’s wave of patent expirations — in which blockbusters such as the cholesterol drug Lipitor lose their exclusivity and face cheap generic competition over the next few years — contains a hidden tax hit that will cost billions of
…
0 Comments